CADTH Canadian Drug Expert Committee Recommendation: Brexpiprazole (Rexulti - Lundbeck Canada Inc and Otsuka Canada Pharmaceutical Inc.): Indication: Treatment of schizophrenia in adults [Internet]

Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Nov.
CADTH Common Drug Reviews.
No abstract available

Publication types

  • Review

Grants and funding

Funding: CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.